ArticleACS omega2026
The Landscape of Anti-HBV Activity in Essential Oils: A Machine Learning-Based Virtual Screening Framework and Anti-HBV Activity of
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advanced drug-target interaction prediction using convolutional graph attention networks in expert systems.Molecular diversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Innovative and curative therapies for HBV infection are urgently needed. Essential oils (EOs) offer potential as natural therapeutic alternatives for modulating inflammation and antiviral activity. Extensive screening of anti-HBV EOs promises to yield drug candidates that suppress HBV immune evasion via the modulation of inflammatory pathways, thereby providing new attempts at HBV clearance. This study aimed to investigate the landscape of anti-HBV EOs and develop a virtual screening model to predict the efficacy of EOs against HBV. 292 plant samples were collected and analyzed in terms of extracting their EOs, determining their compositions via GC-MS, and testing their anti-HBV activity. Of the 292 EOs, five EOs exhibited significant anti-HBV activity, including those from
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.